Femasys secures first European order for FemBloc

Femasys (FEMY) announced its first commercial entry into Europe with an order of approximately $400,000 USD for FemBloc Permanent Birth Control in Spain, the first country with an established distribution partnership. “We are proud to be executing on our mission to expand access to FemBloc, an innovative, non-surgical solution and the only advancement in permanent birth control that offers a less invasive alternative to current and formerly available methods,” said Kathy Lee-Sepsick, Chief Executive Officer and Founder of Femasys Inc. “To support that mission, we selected our partners in Spain, Comercial Medico Quirurgica and Durgalab, based on their successful track record commercializing complex women’s health technologies like Essure permanent contraceptive. Their expertise and provider relationships make them ideal collaborators to introduce FemBloc, which will first become available in Spain, the first country in the world to offer access to this groundbreaking option. With a growing backlog of FemBloc product, we are focused on scaling production to meet anticipated demand as interest builds across Europe.”